@drgdiddy $ARWR still very undervalued. $JNJ JNJ-3989 + JNJ-379 + Nuc Drug regimen for CHBV patients still a “VERY BIG STORY.” JNJ-379 CAM, it’s ability to suppress cccDNA early in the HBV-viral lifecycle, is an under-appreciated asset.